Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
24 Cards in this Set
- Front
- Back
|
Most common infection in burn patients
|
Pneumonia
|
|
|
Most common cause of death after inhalation injury
|
Pneumonia
|
|
|
Type of necrosis in acid and alkali burns respectively
|
Coagulation and liquefaction necrosis
|
|
|
Treatment for hydrofluoric acid burns
|
Topical calcium
|
|
|
Cardiac output in early severe burns
|
Decreased (ebb & flow)
|
|
|
Best source of nonprotein calories in burn patients
|
Glucose
|
|
|
Optimal time for burn wound excision
|
<72 hours
|
|
|
Two wound culture results for which skin grafting is contraindicated
|
1. Beta-hemolytic strep
2. Bacteria >100,000 |
|
|
Optimal thickness of STSG and layers involved
|
12-15 mm
epidermis AND some dermis |
|
|
Homografts/allografts eventually result in . . .
|
Rejection at 2-4 weeks (temporizing)
|
|
|
Wounds in these locations should be deferred for one week . . .
|
Face, palms, soles and genitals
|
|
|
Maximum blood loss, skin excision and OR time respectively for each burn excision
|
1L, 20%, 2 hours
|
|
|
Most common reason for skin graft loss
|
Seroma/hematoma
|
|
|
Type of skin graft most likely to survive and why . . .
|
STSG due to imbibition and revascularization
|
|
|
Type of skin graft with less wound contraction . . .
|
FTSG
|
|
|
Two locations where FTSG should be used
|
Face and hands
|
|
|
Most common organism in burn wound infections
|
Pseudomonas
|
|
|
Most common viral infection in burn wounds
|
HSV
|
|
|
Best way to detect a burn wound infection
|
Biopsy
|
|
|
Treatment for ocular burns
|
Topical fluoroquinolone or gentamicin
|
|
|
Location of Curling's ulcer in burn patients
|
Stomach
|
|
|
Name for highly malignant squamous cell CA in chronic nonhealing burn wounds
|
Marjolin's ulcer
|
|
|
Three risk factors for hypertrophic scars in burn patients
|
1. Prolonged healing time (>3 weeks)
2. Healing by secondary intention 3. Flexor surfaces |
|
|
Length of use of xenografts
|
2 weeks (do not vascularize)
|
